Brief: Clovis Oncology Announces Second Quarter 2021 Operating Results
04/08/2021 13:03
Aug 4 (Reuters) - Clovis Oncology Inc CLVS.O :
* CLOVIS ONCOLOGY ANNOUNCES SECOND QUARTER 2021 OPERATING
RESULTS
* Q2 LOSS PER SHARE $0.61
* Q2 EARNINGS PER SHARE ESTIMATE $-0.57 -- REFINITIV IBES
DATA
* $36.8 MILLION IN RUBRACA GLOBAL NET PRODUCT REVENUES FOR
Q2
2021, DOWN 8% VERSUS Q2 2020, DUE TO CONTINUING IMPACT OF
COVID-19
* Q2 EARNINGS PER SHARE VIEW $-0.57, REVENUE VIEW $41.3
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nBw7GtJsJa
Further company coverage: CLVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clovis Oncology
See all newsBrief: Clovis Oncology Inc - On April 5, 2023, Entered Into Asset Purchase Agreement With Pharma& To Sell Product Business For Upfront Payment Of $70 Million
Brief: Clovis Oncology Enters Into Financing Agreement
Brief: Clovis Oncology Inc Received Written Notice From Nasdaq That Company's Common Stock Will Be Delisted From Nasdaq
U.S. STOCKS ON THE MOVE-Nike, Faraday Future, PBF Energy
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber